Receptor-targeted siRNAs.

作者信息

Rossi John J

机构信息

Division of Molecular Biology, Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, 1450 E. Duarte Road, Duarte, CA 91010, USA.

出版信息

Nat Biotechnol. 2005 Jun;23(6):682-4. doi: 10.1038/nbt0605-682.

DOI:10.1038/nbt0605-682

PMID:15940237

Abstract

摘要

相似文献

Receptor-targeted siRNAs.

Nat Biotechnol. 2005 Jun;23(6):682-4. doi: 10.1038/nbt0605-682.

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Nat Biotechnol. 2005 Jun;23(6):709-17. doi: 10.1038/nbt1101. Epub 2005 May 22.

Targeting specific cell types with silencing RNA.

N Engl J Med. 2005 Sep 29;353(13):1410-1. doi: 10.1056/NEJMcibr052492.

siRNA conjugate delivery systems.

Bioconjug Chem. 2009 Jan;20(1):5-14. doi: 10.1021/bc800278e.

On the delivery of small interfering RNAs into mammalian cells.

Expert Opin Drug Deliv. 2005 Jul;2(4):639-51. doi: 10.1517/17425247.2.4.639.

siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.

Drug Discov Today. 2009 Sep;14(17-18):859-65. doi: 10.1016/j.drudis.2009.06.002. Epub 2009 Jun 21.

Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.

J Gene Med. 2009 Sep;11(9):791-803. doi: 10.1002/jgm.1352.

RNAi therapeutics: an update on delivery.

Curr Opin Mol Ther. 2008 Apr;10(2):158-67.

Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.

J Gene Med. 2007 Nov;9(11):994-1001. doi: 10.1002/jgm.1091.

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.

J Hepatol. 2007 Dec;47(6):744-50. doi: 10.1016/j.jhep.2007.06.015. Epub 2007 Jul 26.

引用本文的文献

HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth.

Oncotarget. 2016 Apr 26;7(17):23594-607. doi: 10.18632/oncotarget.8053.

Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Mol Pharm. 2015 Dec 7;12(12):4175-87. doi: 10.1021/acs.molpharmaceut.5b00335. Epub 2015 Nov 9.

DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.

PLoS One. 2012;7(10):e48057. doi: 10.1371/journal.pone.0048057. Epub 2012 Oct 30.

Strategies for targeted nonviral delivery of siRNAs in vivo.

Trends Mol Med. 2009 Nov;15(11):491-500. doi: 10.1016/j.molmed.2009.09.001. Epub 2009 Oct 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Receptor-targeted siRNAs.

Nat Biotechnol. 2005 Jun;23(6):682-4. doi: 10.1038/nbt0605-682.

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Nat Biotechnol. 2005 Jun;23(6):709-17. doi: 10.1038/nbt1101. Epub 2005 May 22.

Targeting specific cell types with silencing RNA.

N Engl J Med. 2005 Sep 29;353(13):1410-1. doi: 10.1056/NEJMcibr052492.

siRNA conjugate delivery systems.

Bioconjug Chem. 2009 Jan;20(1):5-14. doi: 10.1021/bc800278e.

On the delivery of small interfering RNAs into mammalian cells.

Expert Opin Drug Deliv. 2005 Jul;2(4):639-51. doi: 10.1517/17425247.2.4.639.

siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.

Drug Discov Today. 2009 Sep;14(17-18):859-65. doi: 10.1016/j.drudis.2009.06.002. Epub 2009 Jun 21.

Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.

J Gene Med. 2009 Sep;11(9):791-803. doi: 10.1002/jgm.1352.

RNAi therapeutics: an update on delivery.

Curr Opin Mol Ther. 2008 Apr;10(2):158-67.

Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.

J Gene Med. 2007 Nov;9(11):994-1001. doi: 10.1002/jgm.1091.

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.

J Hepatol. 2007 Dec;47(6):744-50. doi: 10.1016/j.jhep.2007.06.015. Epub 2007 Jul 26.

引用本文的文献

HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth.

Oncotarget. 2016 Apr 26;7(17):23594-607. doi: 10.18632/oncotarget.8053.

Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Mol Pharm. 2015 Dec 7;12(12):4175-87. doi: 10.1021/acs.molpharmaceut.5b00335. Epub 2015 Nov 9.

DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.

PLoS One. 2012;7(10):e48057. doi: 10.1371/journal.pone.0048057. Epub 2012 Oct 30.

Strategies for targeted nonviral delivery of siRNAs in vivo.

Trends Mol Med. 2009 Nov;15(11):491-500. doi: 10.1016/j.molmed.2009.09.001. Epub 2009 Oct 19.